Neugut, Alfred I <br/><br/>
FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data.  [electronic resource] 

 -  Clinical colorectal cancer  06 2019 
 - 133-140 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-0674 
<br/><br/><label>Standard No.: </label>10.1016/j.clcc.2019.01.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Camptothecin--analogs & derivatives<br/>Colonic Neoplasms--drug therapy<br/>Drug Utilization--trends<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Kaplan-Meier Estimate<br/>Leucovorin--therapeutic use<br/>Male<br/>Medicare--statistics & numerical data<br/>Neoplasm Staging<br/>Organoplatinum Compounds--therapeutic use<br/>Progression-Free Survival<br/>SEER Program--statistics & numerical data<br/>United States--epidemiology